These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6795702)

  • 1. Efficacy of dacarbazine imidazole carboxamide and mitomycin C combination therapy in patients with adenocarcinoma of the colon refractory to 5-fluorouracil therapy.
    Conroy JF; Roda PI; Brodsky I; Kahn SB; Bulova SI; Pequignot E
    Recent Results Cancer Res; 1981; 79():93-100. PubMed ID: 6795702
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic arterial infusion for liver metastases from colon cancer: comparison of mitomycin C(NSC-26980) and 5-fluorouracil (NSC-19893).
    Fortuny IE; Theologides A; Kennedy BJ
    Cancer Chemother Rep; 1975; 59(2 Pt 1):401-4. PubMed ID: 1097098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C.
    Krauss S; Sonoda T; Solomon A
    Cancer; 1979 May; 43(5):1598-603. PubMed ID: 445355
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination of constant-infusion 5-fluorouracil, methyl-CCNU, mitomycin C, and vincristine in advanced colorectal carcinoma.
    Greco FA; Richardson RL; Shulman SF; Oldham RK
    Cancer Treat Rep; 1978 Sep; 62(9):1407-8. PubMed ID: 688289
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
    Engstrom PF; MacIntyre JM; Mittelman A; Klaassen DJ
    Am J Clin Oncol; 1984 Aug; 7(4):313-8. PubMed ID: 6377866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
    Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS
    Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotoxicity from 5-fluorouracil (NSC-19893) administration reproduced by mitomycin C (NSC-26980).
    Nichols M; Bergevin PR; Vyas AC; Hamilin R
    Cancer Treat Rep; 1976 Mar; 60(3):293-4. PubMed ID: 1260786
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitomycin-C alone and in combination with infused 5-fluorouracil to the treatment of disseminated gastrointestinal carcinomas.
    Buroker TR; Kim PN; Baker LH; Ratanatharathron V; Wojtaszak B; Vaitkevicius VK
    Med Pediatr Oncol; 1978; 4(1):35-42. PubMed ID: 342890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic artery 5-fluorouracil and mitomycin-C in previously untreated patients with hepatic metastases from colorectal carcinoma.
    Cowan JD; Easterbrock J; Mills GM; McCracken JD
    Mil Med; 1982 Mar; 147(3):220-3. PubMed ID: 6806715
    [No Abstract]   [Full Text] [Related]  

  • 10. Effective retreatment of patients with colorectal cancer and liver metastases.
    Patt YZ; Peters RE; Chuang VP; Wallace S; Mavligit G
    Am J Med; 1983 Aug; 75(2):237-40. PubMed ID: 6224419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil.
    Kessinger MA; Foley JF; Lemon HM
    Cancer Clin Trials; 1979; 2(4):317-9. PubMed ID: 394867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of mitomycin C, cyclophosphamide, and methotrexate in drug-resistant colorectal carcinoma.
    Presant CA; Ratkin G; Klahr C
    Cancer Treat Rep; 1978 Apr; 62(4):549-50. PubMed ID: 350389
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination cancer chemotherapy by regional intra-arterial or intra-aortic infusion of 5-fluorouracil and mitomycin-C with or without irradiation.
    Miura T; Ishida M; Hatano S
    Jpn J Surg; 1971 Jun; 1(2):133-45. PubMed ID: 5173067
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination of dacarbazine and mitomycin in advanced colorectal cancer.
    Bleiberg H; Clavel M; Nicaise C; Devriendt J; Michel J; Vanderlinden B; Rozencweig M
    Cancer Chemother Pharmacol; 1982 Dec; 10(1):68-9. PubMed ID: 7160047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current protocol approaches in large bowel cancer.
    Carter SK
    Semin Oncol; 1976 Dec; 3(4):433-43. PubMed ID: 793018
    [No Abstract]   [Full Text] [Related]  

  • 17. Microangiopathic hemolytic anemia, noncardiac pulmonary edema, and renal failure after treatment of metastatic adenocarcinoma of the colon with 5-fluorouracil and mitomycin-C: report of a case.
    Claycomb CL; Berkovic M
    J Am Osteopath Assoc; 1986 Aug; 86(8):499-503. PubMed ID: 3093413
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination of dacarbazine, mitomycin C, 5-fluorouracil and vincristine in advanced colorectal cancer.
    Falkson G; Pretorius HL; Falkson HC; Schoeman HS
    Cancer Chemother Pharmacol; 1983; 11(3):203-4. PubMed ID: 6416696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The need for pilot studies and surgery-only controls in adjuvant therapy trials for large-bowel cancer.
    Weber-Stadelmann W
    Recent Results Cancer Res; 1985; 98():126-9. PubMed ID: 3929343
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhancement of antitumor effect of cytotoxic agents by bestatin.
    Abe F; Shibuya K; Ashizawa J; Takahashi K; Horinishi H; Matsuda A; Ishizuka M; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1985 Mar; 38(3):411-4. PubMed ID: 3924871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.